Shearwood McClelland III shared a post on X:
”Once again grateful to the Radiation Oncology Institute for recognizing our Navigator-Assisted Hypofractionation (NAVAH) program expansion to help Hispanic breast cancer patients with 1 of the 4 innovation grants awarded nationally this year!”
Source: Shearwood McClelland III/X
Shearwood McClelland III, M.D., is the Director of Spine Oncology at University Hospitals’ Department of Radiation Oncology. His research focuses on improving radiation therapy access for underrepresented minorities using hypofractionation and addressing healthcare disparities. He also led the first U.S. analysis of spine stereotactic body radiation therapy (SBRT) usage.